M
ultiple approaches have been developed in an effort to optimize the bellows-like action of the chest during cardiopulmonary resuscitation (CPR) to improve upon the currently dismal results with manual closed-chest CPR (1) (2) (3) (4) . Two noninvasive technologies consisting of active compression-decompression (ACD) CPR and an impedance threshold device (ITD), when combined, provide near-normal blood flow to the brain and >70% of normal blood flow to the heart (5, 6). These devices were recently shown to increase survival rates with favorable neurological outcomes in patients with cardiac arrest when compared with standard CPR (7) . The ACD CPR device is used to compress and actively decompress the chest and serves as the external motor to power the bellows-like movement of the thorax. The ITD selectively prevents the inflow of respiratory gases during the decompression phase, thus capturing the kinetic recoil energy of the chest and generating a greater and more prolonged negative intrathoracic pressure. By augmenting negative intrathoracic pressure during the decompression phase of CPR, this device combination provides a means to enhance venous blood flow back to the chest to refill the heart and simultaneously lowers intracranial pressures (ICPs). These two physiological mechanisms may contribute to the beneficial effects of these two technologies, which include increased coronary and cerebral perfusion in animals and improved survival rates in humans (5, (7) (8) (9) (10) (11) (12) . Changes in ICP have not been measured previously during ACD CPR + ITD. Thus, the objectives of this study were to demonstrate that this device combination can increase 24-hr survival rates with favorable neurological function in an animal model of prolonged cardiac arrest and to elucidate a possible mechanism for the survival benefit.
Objective: Generation of negative intrathoracic pressure during the decompression phase of cardiopulmonary resuscitation enhances the refilling of the heart. We tested the hypothesis that when compared with closed-chest manual compressions at 80 chest compressions per min, treatment with active compression-decompression cardiopulmonary resuscitation at 80 chest compressions/min combined with augmentation of negative intrathoracic pressure would lower intracranial pressure and increase cerebral perfusion, thereby improving neurologically intact survival rates following prolonged untreated cardiac arrest.
Design: Prospective, randomized animal study. Setting: Animal laboratory facilities. Subjects: A total of 26 female farm pigs in two different protocols (n = 17 and n = 9).
Interventions, Measurements, and Main Results: Seventeen pigs were subjected to 8.5 mins of untreated ventricular fibrillation and prospectively randomized to cardiopulmonary resuscitation at 80 chest compressions/min or active compression-decompression cardiopulmonary resuscitation at 80 chest compressions/min plus an impedance threshold device. Coronary perfusion pressures (29.5 ± 2.7 mm Hg vs. 22.4 ± 1.6 mm Hg, p = .03), carotid blood flow (44.0 ± 12.2 vs. 30.9 ± 10.4, p = .03), and 24-hr neurological survival (88% vs. 22%, p = .015) were higher with active compression-decompression cardiopulmonary resuscitation + an impedance threshold device. Cerebral perfusion pressures, measured in nine additional pigs, were improved with active compression-decompression cardiopulmonary resuscitation + an impedance threshold device (21.9 ± 1.2 mm Hg vs. 8.9 ± 0.8 mm Hg, p < .0001). With active compression-decompression cardiopulmonary resuscitation + impedance threshold device, mean diastolic intracranial pressure during decompression was lower (12.2 ± 0.2 mm Hg vs. 16.6 ± 1.2 mm Hg, p = .02) and the downward slope of the decompression phase intracranial pressure curve was steeper (−60.3 ± 12.9 mm Hg vs. −46.7 ± 11.1 mm Hg/sec, p < .001).
Conclusions: Active compression-decompression cardiopulmonary resuscitation + an impedance threshold device increased cerebral perfusion pressures and lowered diastolic intracranial pressure and intracranial pressure rate during the decompression phase. These mechanisms may underlie the observed increase in cerebral perfusion pressure, carotid blood flow, and survival rates with favorable neurologic outcomes in this pig model of cardiac arrest. ( 
Device Description
A prototype manual device was developed to perform ACD CPR and CPR at 80 CC/min that provided accurate feedback to the user related to compression and decompression forces. It was secured to the chest with an adhesive engineered to withstand up to 30 lbs of decompressive force. The device consisted of an ergonomic handle, electronics to measure compression and decompression forces, a compression pad, and an adhesive pad. An ITD (ResQPOD; Advanced Circulatory Systems, Roseville, MN) provided inspiratory resistance of up to 10 cm H 2 O to augment negative intrathoracic pressure during the chest recoil phase, as has been described previously (5, 6, (13) (14) (15) (16) (17) .
Preparatory Phase
The surgical preparation and monitoring techniques have been described previously (6, 17) . Briefly, initial sedation was achieved with 7 mL (100 mg/mL) of intramuscular ketamine HCl (Ketaset; Fort Dodge Animal Health, Fort Dodge, IA) followed by an intravenous bolus of propofol (PropoFlo; Abbott Laboratories, North Chicago, IL) (2.3 mg/kg), via the lateral ear vein. The trachea was intubated with a 7.5-mm cuffed endotracheal tube inflated to prevent air leaks.
A Millar catheter (Mikro-Tip Transducer; Millar Instruments, Houston, TX) was used to continuously measure central aortic pressure and acquire arterial blood gases. Carotid artery flow was measured using an ultrasound flow probe attached to the internal carotid artery (Transonic Systems, Ithaca, NY). Endotracheal pressures were measured as a surrogate for intrathoracic pressures, with a micromanometer-tipped Millar catheter positioned 2 cm below the tip of the endotracheal tube. These pressures correlate closely with intrathoracic pressures and right atrial pressures during the chest wall decompression phase of CPR (18) .
All data were digitized using a computerized data analysis program (Superscope II vl.295; GW Instruments, Somerville, MA) and a Power Macintosh G3 computer (Apple Computer, Cupertino, CA). End-tidal CO 2 , tidal volume, and arterial oxygen saturation were recorded with a CO 2 SMO Plus (Novametrix Medical Systems, Wallingford, CT).
Protocols
Protocol 1: Survival Study. The survival study was performed according to Utstein-style guidelines on 17 female farm pigs (28 ± 0.6 kg) (19) . VF was induced in the anesthetized animal with a 50-Hz, 7.5-V AC electrical current through a right ventricular endocardial electrode. After 8.5 mins of untreated cardiac arrest, animals were randomized to 6 mins of CPR at 80 CC/min or ACD CPR + ITD at 80 CC/min. This model did not include bystander CPR, a common clinical scenario. The model represents a clinically relevant VF time if no bystander CPR is performed and either Basic or Advanced Life Support crews provide CPR. In contrast to many prior animal studies with ACD CPR + ITD, in this study both methods of CPR were performed manually by a single emergency medical technician trained individual to assure uniformity of CPR delivery throughout the protocol. To assure that the compression force was matched between groups, the rescuer was able to observe the amount of force applied to the chest on a beat-to-beat real-time basis. Furthermore, an audible metronome was used to guide the compression rate. This afforded the operator instantaneous feedback so that the compression rate and force were indistinguishable between groups. In this study, ACD CPR was performed with the device secured to the chest by an adhesive pad. CPR at 80 CC/min was performed with the same device but without being secured to the chest by the adhesive, thus allowing for the same target compression forces and preventing ACD.
All animals were ventilated during CPR with supplemental oxygen (2 L/min) with a bag-valve resuscitator (Smart Bag, O2 Systems, Ontario, Canada), with continuous uninterrupted chest compressions, a compression/ventilation ratio of 10:1, asynchronous ventilations, and a tidal volume of approximately 400 mL. All compressions were performed at a rate of 80 CC/min. After 6 mins of CPR, each animal was immediately defibrillated with up to three sequential 200 J transthoracic biphasic (Zo ll M-Series; Zoll Medical, Chelmsford, MA) shocks. Animals that remained in cardiac arrest received a single dose of intravenous epinephrine (0.045 mg/kg) and an additional 2 mins of CPR. Each animal then received up to three additional sequential 200 J transthoracic shocks. All animals with successful restoration of spontaneous circulation (ROSC) were reconnected to the ventilator. Pigs were weaned from the ventilator over the subsequent 2 hrs and placed back in their pens overnight. No additional postresuscitation care was provided. Survival rates, complication rates, and neurological status were evaluated 24 hrs after resuscitation. The Swine Neurologic Deficit Score was used to evaluate level of consciousness, respiratory pattern, cranial nerve function, motor and sensory function, and behavior evaluation, including ability to drink, chew, stand, and walk (20) . The Cerebral Performance Score, a neurological assessment based on a 5-point evaluation of the level of consciousness, was used to determine neurological function. Twenty-four hours after resuscitation, euthanasia was performed by an injection of 10 mL of 10 M potassium chloride solution and necropsy was performed.
Protocol 2: Acute Study. The same surgical preparation, measurement, and recording techniques that were used in the survival study described above were used in the acute protocol with the exception of the insertion of an intracranial bolt. In the acute, mechanism study (n = 9), an intracranial bolt was inserted into the animals and ICPs were measured with a 3.5F micromanometer pressure transducer (Mikro-Tip Transducer; Millar Instruments), as described previously (21) . ICP was not measured in the survival protocol to ensure that neurological assessments were not influenced by the presence of an intracranial bolt. Once the animals were stable and all monitoring devices were in place, VF was induced. Following 8.5 mins of VF, 5 mins of ACD CPR + ITD or CPR at 80 CC/min was initiated and followed by another 5 mins of the alternative method of CPR. The order of the type of CPR was randomized before the start of the study.
Hemodynamic measurements were averaged over three compression cycles at the end of each minute of CPR. Coronary perfusion pressures were calculated as mean diastolic (decompression) aortic pressure minus mean diastolic (decompression) right atrial pressure. Cerebral perfusion pressures (CerPP) were calculated as mean arterial pressure minus mean ICP. Mean carotid flow measurements were averaged over a minute of continuous measurement.
Statistical Analysis
The primary end point of the survival protocol was 24-hr survival with favorable neurological function, as defined by a cerebral performance category score of 1 or 2 (22) . The primary end point for the acute protocol was CerPP. Fisher's exact test was used for survival rate analysis. Hemodynamic and perfusion parameters were analyzed by Student's t test. All data are expressed as mean ± SEM unless otherwise indicated. A p value of <.05 was considered statistically significant. The sample size, for all protocols, was calculated to provide a power of 80%.
RESULTS

Survival Study
The physiological and survival benefits of the combination of ACD CPR + ITD were compared with closed-chest manual CPR at 80 CC/min. The physiological data, including the measurement of airway pressures, atrial and aortic pressures, the calculated coronary perfusion pressure, and end-tidal CO 2 values are shown in Table 1 . As hypothesized, airway pressures during the decompression phase of CPR were significantly lower in the device group (−8.8 ± 0.7 mm Hg) compared with controls (−2.2 ± 0.2 mm Hg, p < .001). Right atrial pressures during the recoil phase were lower with the device combination (−1.2 ± 0.9 mm Hg) vs. controls (3.3 ± 0.2 mm Hg, p = .01), coronary perfusion pressures (29.5 ± 2.7 mm Hg vs. 22.4 ± 1.6 mm Hg, p = .03) were significantly higher, and carotid blood flows were significantly higher with the device combination (43 ± 4.0 mL/min vs. 31 ± 3.5 mL/min, p = .04). Peak end-tidal CO 2 levels, an indirect indicator of circulation during CPR, were significantly higher in the ACD CPR + ITD group (34 ± 0.6 mm Hg vs. 22 ± 0.6 mm Hg, p < .001). Arterial blood gas measurements were measured during the survival study and are summarized in Table 2 . The arterial pH levels were lower in the ACD CPR + ITD group during CPR, presumably a result of the increased circulation causing an increase in the clearance of lactate. Base excess (measured after 5.5 mins of CPR) was −6.3 ± 1.3 mmol/L for the ACD CPR + ITD group and −7.3 ± 1.1 mmol/L for the CPR at 80 CC/min group (p = not significant).
Arterial oxygen content was similar between groups during CPR.
The overall increase in vital organ perfusion pressures was associated with a significant survival benefit. The initial ROSC rate was 44% in the CPR at 80 CC/ min group and 100% in the ACD CPR + ITD group (p < .05). Seven of eight survivors in the ACD CPR + ITD group required one shock for ROSC and three of four survivors in the CPR at 80 CC/min group required one shock. Once ROSC was achieved, all animals survived 24 hrs. Five of nine CPR at 80 CC/min animals received a total of six shocks plus epinephrine, but ROSC did not occur.
The main study end point, defined a priori, was 24-hr survival with favorable neurological function. The results are summarized in Table 3 . Following 8.5 mins of VF, the nine animals treated with CPR at 80 CC/min had significantly poorer outcomes compared with eight pigs treated with the ACD CPR + ITD. One animal in the ACD CPR + ITD group was excluded from analysis when it was determined that the load cell to measure compression forces was incorrectly calibrated even though the animal survived 24 hrs with intact neurological function.
Twenty-four hour survival was 44% in the CPR at 80 CC/min group and 100% in the ACD CPR + ITD group (p < .05). The cerebral performance score, based on a 5-point scoring system (1 = normal, 5 = brain death), was used to evaluate neurological function at 24 hrs. Twenty-four hour survival with good neurological function, defined by a cerebral performance score of 1 or 2, was significantly better in the animals that received treatment with ACD CPR + ITD (88% vs. 22%, p < .02). With only four survivors in the CPR at 80 CC/ min group, there were insufficient data to demonstrate a statistically significant improvement in the Swine Neurological Deficit Score between groups as only two of the four CPR at 80 CC/min 24-hr survival animals had abnormal neurological function after 24 hrs. When the 24-hr survival animals were compared, total deficit score in the CPR at 80 CC/min group was 124 ± 72 vs. 33 ± 17 in the ACD CPR + ITD group (p = .15).
Acute Study
A separate, acute (nonsurvival) study was performed to investigate the mechanism of increased neurological survival demonstrated in the survival study. Mean CerPP in the mechanism study (n = 9) was significantly higher in the ACD CPR + ITD group, especially after prolonged CPR, as shown in mins 8-10 in Figure 1 the entire 10 mins of CPR was also significantly higher (12.0 ± 2.2 mL/minvs. 8.0 ± 1.5 mL/min, p = .008). Notably, regardless of order, carotid blood flow always increased during ACD CPR + ITD use. One animal experienced a broken rib mid-way through the ACD CPR + ITD cycle detectable by a significant spike in aortic pressures during compressions and verified at autopsy; the ACD CPR + ITD data for this animal were excluded. This was the only animal in the Acute Study that experienced a broken rib. Inclusion of this animal in an intention to treat analysis resulted in even higher CerPPs in the ACD CPR + ITD group. Taken together, the combination of the ACD CPR device + ITD provided significantly greater brain perfusion than CPR at 80 CC/min alone. The effects of the CPR interventions on the absolute ICP values and the rate of ICP change during the decompression phase were also assessed. As shown in Table 4 , in the animals where ACD CPR + ITD was performed after CPR at 80 CC/min, the rate of ICP reduction, as measured by the slope of the ICP during the first 10 msecs of decompression, was 1.5 times higher with ACD CPR + ITD (−60.3 ± 12.9 mm Hg/sec) vs. CPR at 80 CC/min (−46.7 ± 11.1 mm Hg/sec, p < .001). Furthermore, the changes in the rate of ICP reduction and the changes in absolute ICP were highly dependent on the order of CPR performed. The difference in the rate of ICP reduction is illustrated in a representative study in Figure 2 . Overall, the ICP was reduced more rapidly with ACD CPR + ITD and the diastolic ICP values were significantly lower with ACD CPR + ITD.
The prototype ACD CPR device functioned as intended during the studies. The adhesive pad stayed in place during compression and decompression and the ergonomic handle was associated with no discomfort during use.
DISCUSSION
The two main objectives of this study were to determine whether ACD CPR with the additional augmentation of negative intrathoracic pressure would increase 24-hr survival rates with favorable neurological function in pigs and to investigate a potential mechanism for this. Building upon prior animal and human studies (5, 6, (15) (16) (17) 19) results from the current study demonstrated that when compared with CPR at 80 CC/min, use of ACD CPR + ITD resulted in significantly higher carotid artery blood flow and CerPP during the decompression phase of CPR. These favorable hemodynamic findings were associated with significantly more pigs with favorable neurological function 24 hrs after cardiac arrest. This is the first time that ACD CPR + ITD has been shown to increase 24-hr survival and favorable neurological function in pigs compared to CPR at 80 CC/min. A large clinical trial recently reported the same beneficial effect of this approach in humans (7) .
The potential link between improved neurological function and changes in ICP during CPR was explored in this investigation. CerPP, indicative of the amount of blood that perfuses the brain with each compression/decompression cycle, was significantly higher with ACD CPR + ITD. Cerebral blood flow measured via radiolabeled microspheres has been measured previously with ACD CPR + ITD and found to be even greater than baseline levels after prolonged arrest (5) . In contrast, performance of CPR at 100 CC/min results in only 25% of normal blood flow to the brain (6) . In this study, we observed that diastolic ICP values were significantly reduced during ACD CPR + ITD; this tracked concurrently and instantaneously with changes in airway pressures as shown in Figure 2 . The lower the ICP, the lower the resistance to forward blood flow to the brain. This is the first time that ICPs have been shown to be decreased with ACD CPR + ITD. These findings provide a hemodynamic basis and mechanism for the increase in circulation observed in prior animal studies with ACD CPR + ITD. The reduction in ICP overtime was consistently and significantly greater and faster with ACD CPR + ITD in this study. This is reflected by the 1.5-fold higher negative slopes in the ACD CPR + ITD group. The steeper negative ICP slope during ACD CPR + ITD results in more time during each decompression phase for greater cerebral perfusion, thus increasing the time for delivery of blood and oxygen to cerebral tissues, as cerebral blood flow resistance to forward flow generated by ICP is lower for a longer period of time. This is a new observation and one which may help to further explain, at a mechanistic level, the beneficial effects of ACD CPR + ITD. Optimization of this important thoracocerebral pressure relationship, which we and others have described (23, 24) , may be fundamental to optimizing neurological outcomes in cardiac arrest (8, 9, 11) . Another important observation from this investigation is that the coronary perfusion pressures were higher in the control (CPR at 80 CC/min) group than what has previously been observed in other CPR studies (17) . We speculate that these differences are due to the larger footprint of the CPR device used in these studies which is about 1.5 times larger than a "standard" size of the human palm.
The larger surface area of the compression surface presumably confers a hemodynamic benefit on its own, by spreading the same force-out over a larger compressible area.
There are limitations in this study. First, although the study was prospective and animals were randomized to the method of CPR after induction of VF, the study could not be blinded. However, as noted above, compression rate and force were closely monitored and controlled. Second, although the results of this novel study demonstrate a significant increase in CerPP and carotid blood flow with ACD CPR + ITD, we did not measure actual vital organ blood flow. Nonetheless, the effects on perfusion pressures, and the survival and neurological benefit observed in this study with the use of ACD CPR + ITD suggest that blood flow was significantly higher with ACD CPR + ITD. Third, CPR was performed at 80 CC/ min instead of the AHA-recommended 100 CC/min so that both groups were matched for CC rate. CPR results may have improved at 100 CC/min. Finally, in contrast to standard clinical postcardiac arrest care, no substantial post-ROSC care was provided to animals in the either group. It is possible that additional post-ROSC care may have changed the study outcomes.
CONCLUSION
When compared with CPR at 80 CC/ min, application of the ACD CPR device combined with the ITD during pig studies resulted in: 1) a significant improvement in coronary and CerPPs, end-tidal CO 2 , and carotid artery blood flow; 2) a significant improvement in 24-hr survival with favorable neurological function; 3) a significant reduction in ICP during the decompression phase of CPR; and 4) a more rapid decline in ICP table 4. Acute protocol (mean ± SEM) measurements of the changes in the rate of intracranial pressure reduction during the decompression phase of cardiopulmonary resuscitation and the absolute intracranial pressure values (systolic, diastolic, mean)
